Kathleen Sebelius
CIK: 0001654316
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 11, 2026HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
80K shares- - May 19, 2026HUMA
Humacyte, Inc.
Purchase(P)Direct56.8K shares at avg. $0.88$50K - Jun 12, 2025HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
80K shares- - Apr 8, 2025HUMA
Humacyte, Inc.
Purchase(P)Direct50K shares at avg. $1.32$66K - Sep 10, 2024HUMA
Humacyte, Inc.
Exercise(M)Direct2.5K shares at avg. $3.35$8K - Sep 10, 2024HUMA
Humacyte, Inc.
Sale(S)Direct1.5K shares at avg. $5.39$8K - Sep 10, 2024HUMA
Humacyte, Inc.
Sale(S)Direct3.6K shares at avg. $5.41$20K - Sep 10, 2024HUMA
Humacyte, Inc.
Exercise(M)Direct4.5K shares at avg. $4.34$20K - Jun 13, 2024EXAS
EXACT SCIENCES CORP
Award(A)Direct7.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 80,000 | - | - | Direct |
| May 19, 2026 | HUMA Humacyte, Inc. | Purchase(P) | 56,818 | $0.88 | $50,000 | Direct |
| Jun 12, 2025 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 80,000 | - | - | Direct |
| Apr 8, 2025 | HUMA Humacyte, Inc. | Purchase(P) | 50,000 | $1.32 | $66,000 | Direct |
| Sep 10, 2024 | HUMA Humacyte, Inc. | Exercise(M) | 2,479 | $3.35 | $8,305 | Direct |
| Sep 10, 2024 | HUMA Humacyte, Inc. | Sale(S) | 1,548 | $5.39 | $8,344 | Direct |
| Sep 10, 2024 | HUMA Humacyte, Inc. | Sale(S) | 3,634 | $5.41 | $19,660 | Direct |
| Sep 10, 2024 | HUMA Humacyte, Inc. | Exercise(M) | 4,521 | $4.34 | $19,621 | Direct |
| Jun 13, 2024 |  EXAS EXACT SCIENCES CORP | Award(A) | 7,672 | - | $0 | Direct |
1-9 of 9 transactions
About Sebelius Kathleen
Sebelius Kathleen (SEC CIK 0001654316) files insider reports with the SEC as Director of Humacyte, Inc. (HUMA) and Director of EXACT SCIENCES CORP (EXAS).
Signal8 holds 6 ownership filings by Sebelius Kathleen, all Form 4s, filed between Sep 11, 2024 and Jun 12, 2026. Those filings report 9 transactions, from Jun 13, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sebelius Kathleen's filings is in DURHAM, NC.
Recent filings by Sebelius Kathleen
- Jun 11, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
- May 19, 2026: Open-market purchase of HUMA shares (Form 4, code P).
- Jun 12, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
- Apr 8, 2025: Open-market purchase of HUMA shares (Form 4, code P).
- Sep 10, 2024: Option exercise of HUMA shares (Form 4, code M).
Other insiders filing for Humacyte, Inc. (HUMA)
- COWARD D SCOTT, Director
- Kuznik Paul Brian, Director
- Jones Keith Anthony, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director